Outcome | Placebo arm | Non-treatment arm | ||
---|---|---|---|---|
 | Recruited vs non-recruited | Recruited vs non-recruited | ||
 | HR (95% CI), crude | HR (95% CI), adjusted* | HR (95% CI), crude | HR (95% CI), adjusted* |
Coronary heart disease | 0.81 (0.62-1.04) | 0.80 (0.62-1.03) | 1.02 (0.82-1.28) | 1.06 (0.84-1.33) |
Cancer | 1.00 (0.58-1.70) | 0.97 (0.57-1.66) | 0.71 (0.42-1.20) | 0.75 (0.44-1.29) |
Cerebrovascular disease | 0.43 (0.26-0.71) | 0.44 (0.27-0.73) | 0.86 (0.59-1.26) | 0.90 (0.61-1.31) |
Bone fractures | 0.89 (0.67-1.18) | 0.88 (0.67-1.17) | 1.28 (0.97-1.69) | 1.30 (0.98-1.72) |
Total mortality | 0.51 (0.22-1.19) | 0.51 (0.23-1.22) | 0.72 (0.33-1.55) | 0.80 (0.34-1.74) |
All outcomes combined | 0.76 (0.63-0.91) | 0.75 (0.63-0.91) | 1.05 (0.89-1.25) | 1.09 (0.92-1.30) |